Search Results - "гипертермическая интраоперационная внутрибрюшная химиотерапия"

1

Academic Journal

Treatment outcomes in young adults with gastric cancer ; Результаты лечения рака желудка у больных молодого возраста

Source: Siberian journal of oncology; Том 23, № 6 (2024); 7-21 ; Сибирский онкологический журнал; Том 23, № 6 (2024); 7-21 ; 2312-3168 ; 1814-4861

Subject Terms: внутрибрюшная аэрозольная химиотерапия под давлением, multimodal treatment, hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC), pressurized intraperitoneal aerosol chemotherapy (PIPAC), комбинированное лечение, гипертермическая интраоперационная внутрибрюшная химиотерапия

File Description: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/3359/1303; Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. doi:10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020; 70(4): 313. doi:10.3322/caac.21609.; Camargo M.C., Anderson W.F., King J.B., Correa P., Thomas C.C., Rosenberg P.S., Eheman C.R., Rabkin C.S. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011; 60(12): 1644–9. doi:10.1136/gut.2010.236737.; Isobe T., Hashimoto K., Kizaki J., Miyagi M., Aoyagi K., Koufuji K., Shirouzu K. Characteristics and prognosis of gastric cancer in young patients. Oncol Rep. 2013; 30(1): 43–9. doi:10.3892/or.2013.2467.; Hsieh F.J., Wang Y.C., Hsu J.T., Liu K.H., Yeh C.N. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol. 2012; 105(3): 304–9. doi:10.1002/jso.22084.; Wang Z., Xu J., Shi Z., Shen X., Luo T., Bi J., Nie M. Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol. 2016; 51(9): 1043–9. doi:10.1080/00365521.2016.1180707.; Lee J.H., Ryu K.W., Lee J.S., Lee J.R., Kim C.G., Choi I.J., Park S.R., Kook M.C., Kim Y.W., Bae J.M. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly. J Surg Oncol. 2007; 95(6): 485–90. doi:10.1002/jso.20707.; Takatsu Y., Hiki N., Nunobe S., Ohashi M., Honda M., Yamaguchi T., Nakajima T., Sano T. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2016; 19(2): 472–78. doi:10.1007/s10120-015-0484-1.; Rona K.A., Schwameis K., Zehetner J., Samakar K., Green K., Samaan J., Sandhu K., Bildzukewicz N., Katkhouda N., Lipham J.C. Gastric cancer in the young: An advanced disease with poor prognostic features. J Surg Oncol. 2017; 115(4): 371–75. doi:10.1002/jso.24533.; Kim K.H., Kim Y.M., Kim M.C., Jung G.J. Analysis of prognostic factors and outcomes of gastric cancer in younger patients: a case control study using propensity score methods. World J Gastroenterol. 2014; 20(12): 3369–75. doi:10.3748/wjg.v20.i12.3369.; Liu S., Feng F., Xu G., Liu Z., Tian Y., Guo M., Lian X., Cai L., Fan D., Zhang H. Clinicopathological features and prognosis of gastric cancer in young patients. BMC Cancer. 2016; 16: 478. doi:10.1186/s12885-016-2489-5.; Park J.C., Lee Y.C., Kim J.H., Kim Y.J., Lee S.K., Hyung W.J., Noh S.H., Kim C.B. Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol. 2009; 99(7): 395–401. doi:10.1002/jso.21281.; Smith B.R., Stabile B.E. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009; 144(6): 506–10. doi:10.1001/archsurg.2009.77.; Saito H., Takaya S., Fukumoto Y., Osaki T., Tatebe S., Ikeguchi M. Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Med. 2012; 55(3): 57–61.; Zhou L., Jiang Z., Gu W., Han S. STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ≤30 years. Medicine (Baltimore). 2021; 100(26). doi:10.1097/MD.0000000000026336.; Huang Q., Zheng X., Jiao Y., Lei Y., Li X., Bi F., Guo F., Wang G., Liu M. A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old. Front Oncol. 2021; 11. doi:10.3389/fonc.2021.674224.; Braga-Neto M.B., Carneiro J.G., de Castro Barbosa A.M., Silva I.S., Maia D.C., Maciel F.S., de Alcântara R.J.A., Vasconscelos P.R.L., Braga L.L.B.C. Clinical characteristics of distal gastric cancer in young adults from Northeastern Brazil. BMC Cancer. 2018; 18(1): 131. doi:10.1186/s12885-018-3995-4.; Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, LIVESTRONG Young Adult Alliance. 2006. 104 p.; Parsons H.M., Harlan L.C., Lynch C.F., Hamilton A.S., Wu X.C., Kato I., Schwartz S.M., Smith A.W., Keel G., Keegan T.H. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012; 30(19): 2393–400. doi:10.1200/JCO.2011.39.6333.; Chung H.W., Noh S.H., Lim J.B. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 2010; 16(2): 256–63. doi:10.3748/wjg.v16.i2.256.; Zhou F., Xu Y., Shi J., Lan X., Zou X., Wang L., Huang Q. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers. Cancer Med. 2016; 5(12): 3403–11. doi:10.1002/cam4.931.; Wang Z.K., Lin J.X., Li P., Xie J.W., Wang J.B., Lu J., Chen Q.Y., Cao L.L., Lin M., Tu R.H., Huang C.M., Zheng C.H. Higher Risk of Lymph Node Metastasis in Young Patients with Early Gastric Cancer. J Cancer. 2019; 10(18): 4389–96. doi:10.7150/jca.30260.; Al-Batran S.E., Homann N., Schmalenberg H., Kopp H.G., Haag G.M., Luley K.B., Schmiegel W.H., Folprecht G., Probst S., Prasnikar N., Thuss-Patience P.C., Fischbach W., Trojan J., Koenigsmann M., Pauligk C., Goetze T.O., Jaeger E., Meiler J., Schuler M.H., Hofheinz R. Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. J. Clin. Oncol. 2017; 35(s15).; Al-Batran S.E., Pauligk C., Homann N., Schmalenberg H., Kopp H., Haag G.M., Luley K., Folprecht G., Probst S., Thuss-Patience P., Trojan J., Koenigsmann M., Lindig U., Pohl M., Kasper S., Moehler M., Goetze T.O., Schuler M., Jaeger E., Hofheinz R.D. LBA27_PR: Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO). Ann. Oncol. 2017; 28(s5). doi:10.1093/annonc/mdx440.019.; Rompen I.F., Nienhüser H., Crnovrsanin N., Musa J., Haag G.M., Longerich T., Fiedler T., Müller-Stich B.P., Sisic L., Billeter A.T. Clinical Characteristics and Oncological Outcomes of Surgically Treated Early-Onset Gastric Adenocarcinoma – a Retrospective Cohort Study. J Cancer. 2023; 14(9): 1470–78. doi:10.7150/jca.82876.; Rau B., Lang H., Koenigsrainer A., Gockel I., Rau H.G., Seeliger H., Lerchenmueller C., Reim D., Wahba R., Angele M., Heeg S., Keck T., Weimann A., Topp S., Piso P., Brandl A., Schuele S., Jo P., Pratschke J., Wegel S., Rehders A., Moosmann N., Gaedcke J., Heinemann V., Trips E., Loeffler M., Schlag P.M., Thuss-Patience P. Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial. J Clin Oncol. 2024; 42(2): 146–56. doi:10.1200/JCO.22.02867.; Маркович В.А., Тузиков С.А., Родионов Е.О., Попова Н.О., Цыганов М.М., Миллер С.В., Подолько Д.В., Цыденова И.А., Ибрагимова М.К., Литвяков Н.В. Комбинированное лечение больных раком желудка IV стадии с канцероматозом брюшины. Сибирский онкологический журнал. 2023; 22(1): 24–34. doi:10.21294/1814-4861-2023-22-1-24-34.; Case A., Prosser S., Peters C.J., Adams R., Gwynne S.; PIPAC UK Collaborative. Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative. Crit Rev Oncol Hematol. 2022; 180. doi:10.1016/j.critrevonc.2022.103846.; An H., Wang P.Y., Liu Y.C. Palliative Gastrectomy Improves the Survival of Patients with Metastatic Early-Onset Gastric Cancer: A Retrospective Cohort Study. Curr Oncol. 2023; 30(9): 7874–90. doi:10.3390/curroncol30090572.; https://www.siboncoj.ru/jour/article/view/3359

Availability: https://www.siboncoj.ru/jour/article/view/3359
https://doi.org/10.21294/1814-4861-2024-23-6-7-21

View record from BASE

2

Academic Journal

Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review) ; Рак желудка: современные подходы и перспективы лечения при канцероматозе брюшины (литературный обзор)

Source: Siberian journal of oncology; Том 20, № 6 (2021); 104-113 ; Сибирский онкологический журнал; Том 20, № 6 (2021); 104-113 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2021-20-6

Subject Terms: внутрибрюшная аэрозольная химиотерапия, cytoreductive surgery, hyperthermic intraoperative intraperitoneal chemotherapy, intraperitoneal aerosol chemotherapy, циторедуктивная хирургия, гипертермическая интраоперационная внутрибрюшная химиотерапия

File Description: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/1992/936; Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov; 68(6): 394–424. doi:10.3322/caac.21492.; Worldwide cancer data. [Internet]. URL: https://www.wcrf.org/dietandcancer/worldwide-cancer-data/ (cited 01.2019).; Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). М., 2020. 252 с.; El-Sedfy A., Brar S.S., Coburn N.G. Current role of minimally invasive approaches in the treatment of early gastric cancer. World J Gastroenterol. 2014 Apr 14; 20(14): 3880–8. doi:10.3748/wjg.v20.i14.3880.; Ellebaek S.B., Graversen M., Detlefsen S., Lundell L., Fristrup C.W., Pfeiffer P., Mortensen M.B. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study. Clin Exp Metastasis. 2020; 37: 325–32. doi:10.1007/s10585-020-10023-5.; Хомяков В.М., Рябов А.Б., Болотина Л.В., Соболев Д.Д., Уткина А.Б., Кузнецова О.С. Лечение больных раком желудка с канцероматозом брюшины. Современный взгляд и перспективы. Онкология. Журнал им. П.А. Герцена. 2017. 6(6): 4–13.; Fujitani K., Yang H.-K., Mizusawa J., Kim Y.-W., Terashima M., Han S.-U., Iwasaki Y., Hyung W.J., Takagane A., Park D.J., Yoshikawa T., Hahn S., Nakamura K., Park C.H., Kurokawa Y., Bang Y.-J., Park B.J., Sasako M., Tsujinaka T., REGATTA study investigators. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomized controlled trial. Lancet Oncol. 2016 Mar; 17(3): 309–18. doi:10.1016/S1470-2045(15)00553-7.; Калинин А.Е., Гущин В.В. Принятие хирургических решений при лечении больных метастатическими злокачественными опухолями. Хирургическое лечение перитонеального канцероматоза. Практическая онкология. 2016. 17(3): 119–28.; Amin M.B., Greene F.L., Edge S.B., Compton C.C., Gershenwald J.E., Brookland R.K., Meyer L., Gress D.M., Byrd D.R., Winchester D.P. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more «personalized» approach to cancer staging. CA Cancer J Clin. 2017 Mar; 67(2): 93–9. doi:10.3322/caac.21388.; Gamboa A.C., Winer J.H. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer. Cancers. 2019; 11: 1662. doi:10.3390/cancers11111662.; Glehen O., Passot G., Villeneuve L., Vaudoyer D., Bin-Dorel S., Boschetti G., Piaton E., Garofalo A. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014; 14: 183.; Yonemura Y., Canbay E., Ishibashi H., Hirano M., Mizumoto A., Takao N., Ichinose M., Noguchi K., Motoi S., Liu Y., Wakama S., Coccolini F., Taniguchi K. Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer. Cancer Regional Therapy. 2020. doi:10.1007/978-3-030-28891-4_10.; Brücher B.L., Piso P., Verwaal V., Esquivel J., Derraco M., Yonemura Y., Gonzalez-Moreno S., Pelz J., Königsrainer A., Ströhlein M., Levine E.A., Morris D., Bartlett D., Glehen O., Garofalo A., Nissan A. Peritoneal carcinomatosis: cytoreductive surgery and HIPEC-overview and basics. Cancer Invest. 2012 Mar; 30(3): 209–24. doi:10.3109/07357907.2012.654871.; Maeda H., Kobayashi M., Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol. 2015 Oct 21; 21(39): 10936–47. doi:10.3748/wjg.v21.i39.10936.; National Comprehensive Cancer Network (NCCN). [Internet]. URL: https://www.nccn.org/professionals/physician_gls/default.aspx (cited 18.10.2019).; Yonemura Y., Prabhu A., Sako S., Ishibashi H., Mizumoto A., Takao N., Ichinose M., Motoi S., Liu Y., Nishihara K., Brandl A., Fushida S. Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis. Cancers. 2020; 12 (1): 116. doi:10.3390/cancers12010116.; Афанасьев С.Г., Добродеев А.Ю. Циторедуктивные операции (Нужно ли удалять первичную опухоль? Где предел разумной циторедукции? Практическая онкология. 2014; 15(2): 93–100.; Sugarbaker P.H., Van der Smitten K. Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol. 2016; 7: 29–44. doi:10.3978/j.issn.2078-6891.2015.105.; Kono K., Yong W.P., Okayama H., Shabbir A., Momma T., Ohki S., Takenoshita S., So J. Intraperitoneal chemotherapy for stomach cancer with peritoneal disease: the experience of Singapore and Japan. Gastric Cancer. 2017; 20: 122–7. doi:10.1007/s10120-016-0660-y.; Walker J.L., Brady M.F., Wenzel L., Fleming G.F., Huang H.Q., DiSilvestro P.A., Fujiwara K., Alberts D.S., Zheng W., Tewari K.S., Cohn D.E., Powell M.A., Van Le L., Davidson S.A., Gray H.J., Rose P.G., Aghajanian C., Myers T., Alvarez Secord A., Rubin S.C., Mannel R.S. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2019 Jun 1; 37(16): 1380–90. doi:10.1200/JCO.18.01568.; Cascales-Campos P.A., López-López V., Torres-Melero J., Arjona A., Muñoz-Casares F.C., Barrios P., Morales R., Pereira F., Bretcha-Boix P., González-Bayón L., González-Moreno S., Gil J. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP). Clin Transl Oncol. 2020; 22: 130–6. doi:10.1007/s12094-019-02124-9.; Quenet F., Elias D., Roca L., Goere D., Ghouti L., Pocard M., Facy O., Arvieux C., Lorimier G., Pezet D., Marchal F., Loi V., Meeus P., Forges H.D., Stanbury T., Paineau J., Glehen O.A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018; 39:1.; Armstrong D.K., Walker J.L. Role of Intraperitoneal Therapy in the Initial Management of Ovarian Cancer. J Clin Oncol. 2019; 37(27): 2416–9.; Yoshida K., Yamaguchi K., Okumura N., Tanahashi T., Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016 Apr; 19(2): 329–38. doi:10.1007/s10120-015-0575-z.; Ansari N., Chandrakumaran K., Dayal S., Mohamed F., Cecil T.D., Moran B.J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol. 2016 Jul; 42(7): 1035–41. doi:10.1016/j.ejso.2016.03.017.; Sugarbaker P.H. Prevention and Treatment of Peritoneal Metastases from Gastric Cancer. J Clin Med. 2021; 10(9): 1899. doi:10.3390/jcm10091899.; The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. Cancer. 2020; 126(11): 2541–6. doi:10.1002/cncr.32868.; Al-Batran S.E., Homann N., Pauligk C., Illerhaus G., Martens U.M., Stoehlmacher J., Schmalenberg H., Luley K.B., Prasnikar N., Egger M., Probst S., Messmann H., Moehler M., Fischbach W., Hartmann J.T., Mayer F., Höffkes H.-G., Koenigsmann M., Arnold D., Kraus T.W., Grimm K., Berkhoff S., Post S., Jäger E., Bechstein W., Ronellenfitsch U., Mönig S., Hofheinz R.D. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial. JAMA Oncol. 2017 Sep 1; 3(9):1237–44. doi:10.1001/jamaoncol.2017.0515.; Хомяков В.М., Соболев Д.Д., Колобаев И.В., Чайка А.В., Уткина А.Б., Корниецкая А.Л., Виндиза Ф.Р., Рябов А.Б. Конверсионная хирургия при раке желудка IV cтадии. Обзор литературы и опыт МНИОИ Им. П.А. Герцена. Вопросы онкологии. 2020; 66(1). С. 50–7.; Sun F., Feng M., Guan W. Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett. 2017 Dec; 14(6):6991–8. doi:10.3892/ol.2017.7149.; Yonemura Y., Iahibashi H., Sako S., Mizumoto A., Takao N., Ichinose M., Motoi S., Liu Y., Wakama S., Kamada Y., Nishihara K. Advances with pharmacotherapy for peritoneal metastasis. Exp Opin Pharmacother. 2020; 21(16): 2057–66. doi:10.1080/14656566.2020.1793957.; Chia C.S., You B., Decullier E., Vaudoyer D., Lorimier G., Abboud K., Bereder J.-M., Arvieux C., Boschetti G., Glehen O., BIG RENAPE Group. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? Ann Surg Oncol. 2016 Jun; 23(6): 1971–9. doi:10.1245/s10434-015-5081-3.; Intraperitoneal Aerosol Chemotherapy in Gastric Cancer (PIPACGA01). [Internet]. URL: https://clinicaltrials.gov/ct2/show/NCT01854255 (cited 04.01.2018).; Bonnot P.E., Piessen G., Pocard M., Meunier B., Bereder J.M., Abboud K., Marchal F., Quenet F., Goere D., Msika S., Arvieux C., Pirro N., Wernert R., RAT P., Pezet D., Lefevre J., Courvoisier T., Kianmanesh R., Meeus P., Glehen O.; FREGAT and BIG-RENAPE Networks. Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. J Clin Oncol. 2019 Aug 10; 37(23): 2028–40. doi:10.1200/JCO.18.01688.; Newhook T.E., Agnes A., Blum M., Estrella J.S., Das P., Ho L., Ajani J.A., Minsky B.D., Mansfield P., Badgwell B.D. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Ann Surg Oncol. 2019 May; 26(5): 1394–1400. doi:10.1245/s10434-018-07140-7.; Badgwell B., Blum M., Das P., Estrella J., Wang X., Ho L., Fournier K., Royal R., Mansfield P., Ajani J. Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. Ann Surg Oncol. 2017 Oct; 24(11): 3338–44. doi:10.1245/s10434-017-6047-4.; Solass W., Kerb R., Mürdter T., Giger-Pabst U., Strumberg D., Tempfer C., Zieren J., Schwab M., Reymond M.A. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014 Feb; 21(2): 553–9. doi:10.1245/s10434-013-3213-1.; Каприн А.Д., Хомяков В.М., Рябов А.Б., Болотина Л.В., Иванов А.В., Черемисов В.В., Колобаев И.В., Чайка А.В., Соболев Д.Д., Крамская Л.В., Уткина А.Б. Внутрибрюшная аэрозольная химиотерапия под давлением у больных диссеминированным раком желудка. Онкология. Журнал им. П.А. Герцена. 2016; 5(2): 12–8. doi:10.17116/onkolog20165212-18.; Dakwar G.R., Shariati M., Willaert W., Ceelen W., de Smedt S.C., Remaut K. Nanomedicine – based intraperitoneal therapy for the treatment of peritoneal carcinomatosis – Mission possible? Adv Drug Deliv Rev. 2017 Jan 1; 108: 13–24. doi:10.1016/j.addr.2016.07.001.; Хомяков В.М., Рябов А.Б., Колобаев И.В., Болотина Л.В., Уткина А.Б., Соболев Д.Д., Кузнецова О.С., Каприн А.Д. Внутрибрюшная аэрозольная химиотерапия под давлением в сочетании с системной химиотерапией – новый подход в лечении больных раком желудка с перитонеальным карциноматозом. Сибирский онкологический журнал. 2020; 19(4): 49–58. doi:10.21294/1814-4861-2020-19-4-49-58; Graversen M., Detlefsen S., Bjerregaard J.K., Fristrup C.W., Pfeiffer P., Mortensen M.B. Prospective, single–center implementation and evaluation of intraperitoneal aerosol pressure chemotherapy (PIPAC) response for peritoneal metastases. Adv Med Oncol. 2018. doi:10.1177/1758835918777036.; Solass W., Sempoux C., Carr N.J., Bibeau F., Neureiter D., Jäger T., Caterino T.D., Brunel C., Klieser E., Fristrup C.W., Mortensen M.B., Detlefsen S. Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis. Histopathology. 2019 Jun; 74(7): 1014–24. doi:10.1111/his.13829.; Thomassen I., van Gestel Y.R., van Ramshorst B., Luyer M.D., Bosscha K., Nienhuijs S.W., Lemmens V.E., de Hingh I.H. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014 Feb 1; 134(3): 622–8. doi:10.1002/ijc.28373.; Ji Z.-H., Peng K.-W., Yu Y., Li X.-B., Yonemura Y., Liu Y., Sugarbaker P.H., Li Y. Current status and future prospects of clinical trials on CRS+HIPEC for gastric cancer peritoneal metastases. Int J Hyperthermia. 2017 Aug; 33(5): 562–70. doi:10.1080/02656736.2017.1283065.; Seshadri R.A., Glehen O. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for stomach cancer. World J Gastroenterol 2016, 22: 1114–30.; Levine E.A., Stewart J.H., Shen P., Russell G.B., Loggie B.L., Votanopoulos K.I. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014 Apr; 218(4): 573–85. doi:10.1016/j.jamcollsurg.2013.12.013.; Coccolini F., Campanati L., Catena F., Ceni V., Ceresoli M., Jimenez Cruz J., Lotti M., Magnone S., Napoli J., Rossetti D., De Iaco P., Frigerio L., Pinna A., Runnebaum I., Ansaloni L. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. J Gynecol Oncol. 2015 Jan; 26(1): 54–61. doi:10.3802/jgo.2015.26.1.54.; https://www.siboncoj.ru/jour/article/view/1992

Availability: https://www.siboncoj.ru/jour/article/view/1992
https://doi.org/10.21294/1814-4861-2021-20-6-104-113

View record from BASE

3

Academic Journal

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER ; ОПЫТ КОМБИНИРОВАННОГО ЛЕЧЕНИЯ БОЛЬНЫХ МЕСТНО-РАСПРОСТРАНЕННЫМ И ДИССЕМИНИРОВАННЫМ РАКОМ ЖЕЛУДКА С ИСПОЛЬЗОВАНИЕМ МЕТОДИКИ ГИПЕРТЕРМИЧЕСКОЙ ИНТРАОПЕРАЦИОННОЙ ВНУТРИБРЮШНОЙ ХИМИОТЕРАПИИ

Authors: A. D. Kaprin, V. M. Khomyakov, D. D. Sobolev, L. V. Bolotina, A. B. Ryabov, V. E. Khoronenko, M. M. Soboleva, L. V. Kramskaya, А. Д. Каприн, В. М. Хомяков, Д. Д. Соболев, Л. В. Болотина, А. Б. Рябов, В. Э. Хороненко, М. М. Соболева, Л. В. Крамская

Source: Research and Practical Medicine Journal; Том 2, № 4 (2015); 17-27 ; Research'n Practical Medicine Journal; Том 2, № 4 (2015); 17-27 ; 2410-1893 ; 10.17709/2409-2231-2015-4

Subject Terms: адьювантная химиотерапия, dissemination, hyperthermic intraperitoneal chemotherapy, adjuvant chemotherapy, диссеминация, гипертермическая интраоперационная внутрибрюшная химиотерапия

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/97/104; Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010; 60 (5): 277–300.; Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008. Int J Cancer. 2010; 15;127 (12): 893–917.; López-Basave H. N., Morales-Vásquez F., Ruiz-Molina J. M., Namendys-Silva S. A., Vela-Sarmiento I., Ruan J. M., Rosciano A. E., Calderillo-Ruiz G., Díaz-Romero C., Herrera-Gómez A., Meneses-García A. A. Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis? Cancer Manag Res. 2013; 4;5: 1–6.; Каприн А. Д., Старинский В. В., Петрова Г. В., 2015. (ред). Состояние онкологической помощи населению России в 2013. М., 2013.; Kaibara N., Sumi K., Yonekawa M., Ohta M., Makino M., Kimura O., Nishidoi H., Koga S. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am. J. Surg. 1990; 159 (2): 18–21.; Онкология: национальное руководство. Под ред. Чиссова В. И., Давыдова М. И. М.: ГЭОТАР-Медиа, 2008.; Oh D. Y., Bang Y. J. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol. 2013; 14 (3): 311–320.; Taketa T., Sudo K., Wadhawa R., Blum M. M., Ajani J. A. Adjuvant therapy in gastric cancer: what is the optimal approach? Curr Oncol Rep. 2013; 15 (2): 146–151.; Gordon M. A., Gundacker H. M., Benedetti J., Macdonald J. S., Baranda J. C., Levin W. J., Blanke C. D., Elatre W., Weng P., Zhou J. Y., Lenz H. J., Press M. F. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT‑0116/SWOG9008 clinical trial. Ann Oncol. 2013; 24 (7): 1754–1761.; Chu D. Z., Lang N. P., Thompson C., Osteen P. K., Westbrook K. C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989; 63 (2): 364–367.; Eltabbakh G. H., Werness B. A., Piver S., Blumenson L. E. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol. 1998; 71 (2): 230–239.; Puhlmann M., Fink U., Siewert J. R. Value of tumor debulking in gastrointestinal tumors. Chirurg. 1999; 70 (12): 1408–1414.; Makino M., Kaibara N., Kimura O., Nishidoi H., Koga S. Correlation between subserosal venous invasion by gastric cancer and the occurrence of liver metastasis. Am J Clin Oncol. 1989; 12 (5): 407–410.; Bozzetti F., Bonfanti G., Audisio R. A., Doci R., Dossena G., Gennari L., Andreola S. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet. 1987; 164 (2): 151–154.; Santoro E., Garofalo A., Carlini M., Rinaldi G., Santoro E. Early and late results of 100 consecutive total gastrectomies for cancer. Hepatogastroenterology. 1994; 41 (5): 489–496.; Sugarbaker P. H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Michig an: Ludann Company, 1998.; Sadeghi B., Arvieux C., Glehen O., Beaujard A. C., Rivoire M., Baulieux J., Fontaumard E., Brachet A., Caillot J. L., Faure J. L., Porcheron J., Peix J. L., François Y., Vignal J., Gilly F. N. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000; 88 (2): 358–363.; Jacquet P., Vidal-Jove J., Zhu B. W., Sugarbaker P. Peritoneal carcinomatosis from intraabdominal malignancy: natural history and new prospects for management. Acta Belg Chir. 1994; 94 (4): 191–197.; Jacquet P., Stuart O. A., Chang D., Sugarbaker P. H. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996; 7 (5): 596–603.; Sugarbaker P. H. Review of a personal experience in the management of carcinomatosis and sarcomatosis Jpn J Clin Oncol. 2001; 31 (12): 573–583.; Beaujard A. C., Glehen O., Caillot J. L., Francois Y., Bienvenu J., Panteix G., Garbit F., Grandclément E., Vignal J., Gilly F. N. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer. 2000; 88 (11): 2512–2519.; Ceelen W. P., Flessner M. F. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010; 7 (2): 108–115.; Lippmann H. G., Graichen D., Sarembe B., Schmidt D., Löffler I., Schilling W., Preissler J. Clinical examination of the conception ‘86 of «Canсer Multistep-Therapie» (CMT) by M. v. Ardene. Arch Geschwulstforsch. 1976; 46 (7): 568–609.; Spratt J. S., Adcock R. A., Muskovin M., Sherrill W., McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980; 40 (2): 256–60.; Athanasoulis C. A., Baum S., Rösch J., Waltman A. C., Ring E. J., Smith J. C. Jr, Sugarbaker E., Wood W. Mesenteric arterial infusions of vasopressin for hemorrhage from colonic diverticulosis. Am J Surg. 1975; 129 (2): 212–6.; Storm F. K. Clinical hyperthermia and chemotherapy. Radiol Clin North Am. 1989; 27 (3): 621–7.; Jacquet P., Stephens A. D., Averbach A. M., Chang D., Ettinghausen S. E., Dalton R.R, Steves M. A., Sugarbaker P. H. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996; 77 (12): 2622–2629.; Kunisaki C., Shimada H., Nomura M, Matsuda G., Otsuka Y., Akiyama H. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg. 2004; 91 (10):1319–1324.; Kochi M., Fujii M., Kanamori N., Kaiga T., Takahashi T., Kobayashi M., Takayama T. Neoadjuvant chemotherapy with S‑1 and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol. 2006; 132 (12): 781–785.; Costa W. L., Jr, Coimbra F. J., Ribeiro H. S., Diniz A. L., de Godoy A. L., Begnami M., Silva M. J., Fanelli M. F., Mello C. A. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients. World J Surg Oncol. 2012; 19 (10): 195.; https://www.rpmj.ru/rpmj/article/view/97

Availability: https://www.rpmj.ru/rpmj/article/view/97
https://doi.org/10.17709/2409-2231-2015-2-4-17-27

View record from BASE

4

Academic Journal